| DHA‐P versus artesunate plus sulfadoxine‐pyrimethamine | ||||||
| Trial ID | Sample Size | Blinding | Clinical symptoms monitoring | Biochemistry | Haematological | ECG |
| Karunajeewa 2008 PNG | 245 | Open label | Clinical assessment on days 0, 1, 2, 3, 7, 14, 28, and 42 | None | None | None |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.